| Trial ID: | L0048 |
| Source ID: | NCT03590626
|
| Associated Drug: |
Dulaglutide
|
| Title: |
Effect of Dulaglutide on Liver Fat in Patients With Type 2 Diabetes and Nonalcoholic Fatty Liver Disease
|
| Acronym: |
D-LIFT
|
| Status: |
Completed
|
| Study Results: |
No Results Available
|
| Results: |
--
|
| Conditions: |
Non Alcoholic Fatty Liver Disease|Type2 Diabetes Mellitus
|
| Interventions: |
Drug: Dulaglutide
|
| Outcome Measures: |
Change in liver fat|Change in Biochemical Markers|Change in Fibroscan Parameters|change in cardiometabolic markers
|
| Sponsor/Collaborators: |
Medanta, The Medicity, India
|
| Gender: |
All
|
| Age: |
20 Years to 70 Years ?? (Adult, Older Adult)
|
| Phases: |
Not applicable
|
| Enrollment: |
60
|
| Study Type: |
Interventional
|
| Study Designs: |
Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Treatment
|
| Start Date: |
January 1, 2019
|
| Completion Date: |
February 18, 2020
|
| Results First Posted: |
--
|
| Last Update Posted: |
February 20, 2020
|
| Locations: |
Division Of Endocrinology & Diabetes, Medanta The Medicity, Gurgaon, Haryana, India
|
| URL: |
https://ClinicalTrials.gov/show/NCT03590626
|
